(Total Views: 320)
Posted On: 12/16/2020 7:08:03 PM
Post# of 36563
Obviously Generex had short time periods better than CYDY. I root for everyone to make money, but this constant comparison like CYDY is GSK or something is a bit much.
“The Company has concluded it will be far more time efficient to forego the second interim analysis and to analyze the data on 390 patients and to provide final data to the U.S. Food and Drug Administration, Health Canada, U.K.’s MHRA, and Philippines FDA, as soon as it is available.” Anna Gluskin would write that.
“The Company has concluded it will be far more time efficient to forego the second interim analysis and to analyze the data on 390 patients and to provide final data to the U.S. Food and Drug Administration, Health Canada, U.K.’s MHRA, and Philippines FDA, as soon as it is available.” Anna Gluskin would write that.
(0)
(0)
